X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3139) 3139
Newsletter (614) 614
Publication (387) 387
Book Chapter (21) 21
Book Review (17) 17
Newspaper Article (15) 15
Book / eBook (6) 6
Journal / eJournal (5) 5
Web Resource (5) 5
Conference Proceeding (4) 4
Dissertation (4) 4
Magazine Article (4) 4
Data Set (2) 2
Streaming Video (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
kala-azar (3393) 3393
humans (1754) 1754
visceral leishmaniasis (1569) 1569
animals (1357) 1357
index medicus (1348) 1348
parasitic diseases (1333) 1333
male (1045) 1045
female (1036) 1036
leishmaniasis (866) 866
tropical medicine (803) 803
research (790) 790
parasitology (788) 788
infectious diseases (705) 705
adult (680) 680
diagnosis (657) 657
immunology (619) 619
leishmaniasis, visceral - epidemiology (563) 563
leishmaniasis, visceral - diagnosis (532) 532
leishmaniasis, visceral - drug therapy (529) 529
child (483) 483
adolescent (471) 471
leishmaniasis, visceral - immunology (458) 458
leishmaniasis, visceral - parasitology (450) 450
health aspects (449) 449
dogs (416) 416
middle aged (409) 409
cutaneous leishmaniasis (406) 406
public, environmental & occupational health (405) 405
infection (397) 397
analysis (393) 393
epidemiology (389) 389
microbiology (388) 388
medical research (377) 377
antiprotozoal agents - therapeutic use (364) 364
parasites (363) 363
child, preschool (360) 360
care and treatment (357) 357
india (345) 345
medicine, experimental (329) 329
research article (326) 326
risk factors (297) 297
infections (295) 295
tropical diseases (295) 295
leishmania donovani (282) 282
mice (282) 282
medicine (273) 273
leishmania (266) 266
donovani (261) 261
arctic medicine. tropical medicine (253) 253
young adult (246) 246
leishmania donovani - immunology (244) 244
leishmaniasis, visceral - veterinary (238) 238
leishmaniasis, visceral - prevention & control (236) 236
infant (234) 234
vector-borne diseases (226) 226
antibodies, protozoan - blood (224) 224
sensitivity and specificity (221) 221
public health (220) 220
antigens (217) 217
leishmaniasis, visceral - complications (216) 216
brazil (214) 214
public aspects of medicine (209) 209
leishmania infantum (206) 206
vaccines (196) 196
leishmaniasis, visceral - transmission (194) 194
sudan (193) 193
enzyme-linked immunosorbent assay (190) 190
zoonoses (187) 187
sodium stibogluconate (186) 186
amphotericin b (185) 185
amphotericin b - therapeutic use (183) 183
drug therapy (181) 181
disease transmission (180) 180
antigens, protozoan - immunology (179) 179
infantum (179) 179
direct agglutination-test (175) 175
polymerase chain reaction (175) 175
leishmaniasis, visceral - pathology (174) 174
mice, inbred balb c (172) 172
aged (170) 170
interferon-gamma (170) 170
veterinary sciences (169) 169
drug resistance (167) 167
leishmania donovani - isolation & purification (166) 166
neglected tropical diseases (164) 164
usage (164) 164
azar dermal leishmaniasis (163) 163
treatment outcome (163) 163
medicine and health sciences (160) 160
liposomal amphotericin-b (159) 159
cytokines (154) 154
india - epidemiology (152) 152
miltefosine (151) 151
biology and life sciences (150) 150
dog diseases - parasitology (150) 150
indian kala-azar (146) 146
leishmaniasis, visceral - blood (145) 145
medicine, general & internal (145) 145
antiprotozoal agents - pharmacology (143) 143
leishmania infantum - immunology (143) 143
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3683) 3683
French (35) 35
Portuguese (31) 31
Spanish (30) 30
German (11) 11
Persian (7) 7
Japanese (3) 3
Chinese (2) 2
Italian (2) 2
Turkish (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Post-kala-azar dermal leishmaniasis: a histopathological study, 12/2005
BACKGROUND : Post-kala-azar dermal leishmaniasis follows an attack of visceral leishmaniasis and is caused by the same organism, i.e. Leishmania donovani .... 
Post kala-azar dermal leishmaniasis, Hypopigmented macules, Nodules, Plaques, Histopathology
Journal
Management of visceral leishmaniasis: Indian perspective, 12/2005
Diagnosis and treatment of Indian visceral leishmaniasis (VL) is extremely unsatisfactory. For diagnosis, demonstration of parasites in splenic/marrow smears... 
Amphotericin B, kala-azar, miltefosine, paromomycin, pentavalent antimony, visceral leishmaniasis
Journal
2011
Papers presented at a workshop on Policy issues in Kala azar in South East Asia, held at New Delhi on 27th November 2009. 
Prevention | Kala-azar
Conference Proceeding
Human Immunology, ISSN 0198-8859, 08/2018, Volume 79, Issue 8, p. 616
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1016/j.humimm.2018.05.004 This... 
Kala-azar | Microbiology | Analysis
Journal Article
Therapeutic trial of sodium antimony gluconate alone and in combination with ketoconazole in post-kala-azar dermal leishmaniasis (PKDL), 11/2003
Drugs used in PKDL include parenteral sodium antimony gluconate (SAG), amphotericin-B, pentamidine, and ketoconazole (KTZ). SAG is the most effective one.... 
Dermatology | Post-kala-azar dermal leishmaniasis, Sodium antimony gluconate, Ketoconazole dv03073
Journal
Evaluation of cholinesterase level in an endemic population exposed to malathion suspension formulation as a vector control measure, 03/2004
The manuscript describes a study on the blood cholinesterase (ChE) level in an exposed population at different interval of time after spraying with malathion... 
Tropical Diseases | Microbiology | SRES-slow release emulsified suspension - ChE-cholinesterase - kala-azar - Phlebotomus argentipes. oc04039
Journal
Mucosal and peri-orificial involvement in post-kala-azar dermal leishmaniasis, 09/2004
BACKGROUND AND AIMS: Lesions of post-kala-azar dermal leishmaniasis (PKDL) usually affect the skin. Uncommonly, the involvement of oral and genital mucosae has... 
Dermatology | Post-kala-azar dermal leishmaniasis, oral mucosa, genital lesions, peri-orificial lesions dv04096
Journal
Bulletin de la Societe de pathologie exotique, ISSN 0037-9085, 10/2015, Volume 108, Issue 4, p. 265
La leishmaniose viscerale (LV) constitue un probleme de sante publique en Tunisie. L'objectif de ce travail est d'actualiser les aspects epidemiologiques,... 
Kala-azar | Epidemiology
Journal Article
CLINICAL INFECTIOUS DISEASES, ISSN 1058-4838, 10/2019, Volume 69, Issue 7, pp. 1130 - 1135
Background. Visceral leishmaniasis (VL), caused by the Leishmania donovani complex, is a fatal, neglected tropical disease that is targeted for elimination in... 
INFECTIOUS DISEASES | relapse | MICROBIOLOGY | IgG1 | rapid diagnostic test | KALA-AZAR | cure | IMMUNOLOGY | visceral leishmaniasis
Journal Article
1996, Cuaderno técnico / Organización Panamericana de la Salud, ISBN 9275330441, Volume no. 44, ix, 51
Book
Parasite Immunology, ISSN 0141-9838, 11/2016, Volume 38, Issue 11, p. 698
Canine visceral leishmaniasis (CVL) is caused by the intracellular parasite Leishmania infantum. Increased levels of arginase, nitric oxide (NO.sub.2) and... 
Kala-azar | Tumor necrosis factor | Prostaglandins E
Journal Article
Web Resource
BMC infectious diseases, ISSN 1471-2334, 01/2020, Volume 20, Issue 1, pp. 10 - 13
A visceral leishmaniasis outbreak was reported from a village in a low-endemic district of Bihar, India. Outbreak investigation with house-to-house search and... 
Epidemic | Kala-azar | Outbreak | Visceral leishmaniasis | Migration | Indoor residual spraying
Journal Article
American Journal of Tropical Medicine and Hygiene, ISSN 0002-9637, 01/2010, Volume 82, Issue 1, pp. 9 - 11
We estimated the level of under-reporting of visceral leishmaniasis (VL) cases by comparing the actual reported cases with those expected as estimated using... 
PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | KALA-AZAR | TROPICAL MEDICINE
Journal Article
Nature Reviews Microbiology, ISSN 1740-1526, 11/2007, Volume 5, Issue 11, pp. S30 - S39
Journal Article
International Journal of Infectious Diseases, ISSN 1201-9712, 04/2015, Volume 33, p. 135
* Tumour necrosis factor (TNF) is an important component of the immune response against leishmaniasis infection. * A patient on anti-TNF therapy may develop... 
Kala-azar | Tumor necrosis factor | Immunotherapy
Journal Article
COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, ISSN 0927-7757, 12/2019, Volume 582, p. 123852
Leishmaniasis is a notorious disease affecting mainly poor people. Visceral Leishmaniasis (VL) is a clinical form of Leishmaniasis which mainly affects people... 
APOPTOSIS | Promastigotes | EFFICACY | SAFETY | Liposome | CHEMISTRY, PHYSICAL | CARDIOTOXICITY | Halofantrine | COMBINATION | ANTIMALARIAL | Cell death | Leishmania | PAROMOMYCIN | MILTEFOSINE | KALA-AZAR | VISCERAL LEISHMANIASIS
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.